Back to mobile site

Kite Pharma (KITE) Being Defended By Canaccord

May 8, 2017 10:59 AM EDT Send to a Friend
Canaccord Genuity maintains Buy on Kite Pharma (NASDAQ: KITE) price target of $90.00.Analyst Dr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login